文献速递消化道肿瘤与早癌消化内镜

FIT阴性者粪便血红蛋白浓度与后续肿瘤检出率相关的前瞻性研究

Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy.
PubMed 文献 · Gut · 2019-08-27

该研究基于意大利四个人群筛查项目,纳入50-69岁首次FIT受试者,评估两次FIT阴性后累积粪便血红蛋白浓度与后续进展期肿瘤风险的关系。结果显示累积f-Hb浓度越高,后续FIT阳性率、进展期肿瘤检出率和间期结直肠癌风险越高。

要点

  • 两次FIT阴性后累积f-Hb≥20 µg/g者后续两轮FIT阳性率为48.4%,进展期肿瘤检出率25.5%。
  • 累积f-Hb不可测者后续两轮FIT阳性率7.8%,进展期肿瘤检出率1.4%。
  • 间期结直肠癌风险亦与累积f-Hb水平相关。

核心结论

  • 两次FIT阴性后累积粪便血红蛋白浓度与后续进展期肿瘤及间期结直肠癌风险相关。

研究设计与样本

  • 前瞻性队列研究,纳入2004年1月1日至2010年12月31日在意大利四个人群筛查项目中首次接受FIT的50-69岁受试者。

主要发现

  • 两次FIT阴性后累积f-Hb不可测者(占筛查者50%)后续两轮FIT阳性累积概率为7.8%(95%CI 7.5-8.2),累积f-Hb≥20 µg/g者(占0.7%)为48.4%(95%CI 44.0-53.0)。
  • 进展期肿瘤累积检出率在累积f-Hb不可测者为1.4%(95%CI 1.3-1.6),在累积f-Hb≥20 µg/g者为25.5%(95%CI 21.4-30.2)。
  • 结直肠癌累积检出率在累积f-Hb不可测者为0.17%(95%CI 0.12-0.23),在累积f-Hb≥20 µg/g者为4.5%(95%CI 2.8-7.1)。
  • 间期结直肠癌风险亦与累积f-Hb水平相关。

关键数值与推荐

  • 所有项目采用相同检测流程(OC Sensor,Eiken Japan),每2年一次,单样本,阳性阈值20 µg Hb/g粪便。

临床怎么用

  • 两次阴性FIT后累积f-Hb≥20 µg/g粪便者可立即转诊全结肠镜检查。
  • 累积f-Hb不可测者可考虑延长筛查间隔。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the predictive role of faecal haemoglobin (f-Hb) concentration among subjects with faecal immunochemical test (FIT) results below the positivity cut-off for the subsequent risk of advanced neoplasia (AN: colorectal cancer-CRC-or advanced adenoma). DESIGN: Prospective cohort of subjects aged 50-69 years, undergoing their first FIT between 1 January 2004 and 31 December 2010 in four population-based programmes in Italy. METHODS: All programmes adopted the same analytical procedure (OC Sensor, Eiken Japan), performed every 2 years, on a single sample, with the same positivity cut-off (20 µg Hb/g faeces). We assessed the AN risk at subsequent exams, the cumulative AN detection rate (DR) over the 4-year period following the second FIT and the interval CRC (IC) risk following two negative FITs by cumulative amount of f-Hb concentration over two consecutive negative FITs, using multivariable logistic regression models and the Kaplan-Meier method. RESULTS: The cumulative probability of a positive FIT result over the subsequent two rounds ranged between 7.8% (95% CI 7.5 to 8.2) for subjects with undetectable f-Hb at the initial two tests (50% of the screenees) and 48.4% (95% CI 44.0 to 53.0) among those (0.7% of the screenees) with a cumulative f-Hb concentration ≥20 µg/g faeces. The corresponding figures for cumulative DR were: 1.4% (95% CI 1.3 to 1.6) and 25.5% (95% CI 21.4 to 30.2) for AN; 0.17% (95% CI 0.12 to 0.23) and 4.5% (95% CI 2.8 to 7.1) for CRC. IC risk was also associated with cumulative f-Hb levels. CONCLUSION: The association of cumulative f-Hb concentration with subsequent AN and IC risk may allow to design tailored strategies to optimise the utilisation of endoscopy resources: subjects with cumulative f-Hb concentration ≥20 µg/g faeces over two negative tests could be referred immediately for total colonoscopy (TC), while screening interval might be extended for those with undetectable f-Hb.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Senore C, Zappa M, Campari C, et al. Faecal haemoglobin concentration among subjects with negative FIT results is associated with the detection rate of neoplasia at subsequent rounds: a prospective study in the context of population based screening programmes in Italy. Gut. 2019. PMID: 31455608. doi:10.1136/gutjnl-2018-318198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。